1. Cai, Yuan, Zeng, Rong, Peng, Jinwu, Xu, Zhijie, Bai, Ning. 2022. The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer. In Aging, 14, 7038-7051. doi:10.18632/aging.204270. https://pubmed.ncbi.nlm.nih.gov/36098688/
2. Lu, Jun, Chen, Zhan, Zhao, Hu, Chen, Shushang, Shao, Jichun. 2020. ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma. In Journal of translational medicine, 18, 101. doi:10.1186/s12967-020-02268-1. https://pubmed.ncbi.nlm.nih.gov/32093682/
3. Li, Xiang, Wang, Nan, Wu, Yutong, Liu, Yidan, Wang, Ruoyu. 2022. ALDH6A1 weakens the progression of colon cancer via modulating the RAS/RAF/MEK/ERK pathway in cancer cell lines. In Gene, 842, 146757. doi:10.1016/j.gene.2022.146757. https://pubmed.ncbi.nlm.nih.gov/35907565/
4. Liu, Zhi-Yong, Lin, Xia-Hui, Guo, Hong-Ying, Dong, Ling, Zhu, Ji-Min. 2024. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. In International journal of biological sciences, 20, 2763-2778. doi:10.7150/ijbs.93075. https://pubmed.ncbi.nlm.nih.gov/38725845/
5. Wang, Hong, Dey, Kaushik Kumar, Chen, Ping-Chung, Beach, Thomas G, Peng, Junmin. 2020. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease. In Molecular neurodegeneration, 15, 43. doi:10.1186/s13024-020-00384-6. https://pubmed.ncbi.nlm.nih.gov/32711556/
6. Marcadier, Julien L, Smith, Amanda M, Pohl, Daniela, Chakraborty, Pranesh, Geraghty, Michael T. 2013. Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria. In Orphanet journal of rare diseases, 8, 98. doi:10.1186/1750-1172-8-98. https://pubmed.ncbi.nlm.nih.gov/23835272/
7. Liu, Song, Cai, Xiaojun, Wang, Tao, Wei, Gangjie, Yan, Shuang. 2022. Downregulation of ALDH6A1 is a New Marker of Muscle Insulin Resistance in Type 2 Diabetes Mellitus. In International journal of general medicine, 15, 2137-2147. doi:10.2147/IJGM.S343727. https://pubmed.ncbi.nlm.nih.gov/35241929/
8. Sass, Jörn Oliver, Walter, Melanie, Shield, Julian P H, Woods, C Geoffrey, Smith, Laurie D. 2011. 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase. In Journal of inherited metabolic disease, 35, 437-42. doi:10.1007/s10545-011-9381-x. https://pubmed.ncbi.nlm.nih.gov/21863277/
9. Zhao, Yanyan, Gu, Shen, Li, Lingjie, Zhang, Shirong, Ma, Shenglin. . A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma. In Neuro-oncology, 25, 2207-2220. doi:10.1093/neuonc/noad115. https://pubmed.ncbi.nlm.nih.gov/37379245/